Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze ARWR stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ARWR investment potential.

What is ARWR stock price today?

Get real-time ARWR stock price, historical data, and price charts on Financhill. Track ARWR performance with our advanced analysis tools.

Is ARWR a good investment?

Evaluate ARWR investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ARWR stock?

To buy ARWR stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ARWR?

View detailed market capitalization data and company valuation metrics for ARWR on our comprehensive analysis page.

What is the P/E ratio of ARWR?

Use our fundamental analysis tools to view ARWR P/E ratio and compare valuation metrics with industry peers.

What are ARWR earnings?

View ARWR earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Arrowhead Pharmaceuticals, Inc. Stock Predictions

Still Time to Get In: RAD Intel at $0.85/Share

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

ARWR
Arrowhead Pharmaceuticals, Inc.

Last Price:

$64.69

Seasonality Move:

40.49%

7 Day Trial

ALL ACCESS PASS

$ 7

This AI Layer Just Raised Its Share Price

Arrowhead Pharmaceuticals, Inc. Stock Forecast

Over the next 52 weeks, Arrowhead Pharmaceuticals, Inc. has on average historically risen by 41.9% based on the past 30 years of stock performance.
Arrowhead Pharmaceuticals, Inc. has risen higher in 14 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 46.67%
Is Arrowhead Pharmaceuticals, Inc. Stock Undervalued?

The current Arrowhead Pharmaceuticals, Inc. [ARWR] share price is $65.08. The Score for ARWR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
ARWR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Arrowhead Pharmaceuticals, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Arrowhead Pharmaceuticals, Inc. has on average historically risen by 41.9% based on the past 30 years of stock performance.

Arrowhead Pharmaceuticals, Inc. Stock Rating

Buy

Arrowhead Pharmaceuticals, Inc. (ARWR) is a Buy

Is Arrowhead Pharmaceuticals, Inc. overpriced?

Arrowhead Pharmaceuticals, Inc. has risen higher in 14 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 46.67%

Arrowhead Pharmaceuticals, Inc. Stock Price History

Is ARWR stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

arrowheadpharma.com

52-Week Data

52-Week High:

66.23

52-Week Low:

9.57

Prediction Charts

Market Cap:

8.8B

Price in USD:

65.08

Volume:

4.4M

Beta:

1.27

Technical Analysis

SMA50:

40.28

SMA100:

30.97

SMA200:

23.13

52-Wk Change:

149.62%

Stock Predictions

Is Arrowhead Pharmaceuticals, Inc. stock public?

Yes, Arrowhead Pharmaceuticals, Inc. is a publicly traded company.
What is the Arrowhead Pharmaceuticals, Inc. stock quote today?

The Arrowhead Pharmaceuticals, Inc. stock price is 65.08 USD today.
How to buy Arrowhead Pharmaceuticals, Inc. stock online?

You can buy Arrowhead Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-13	40.72	41.14	41.50	40.21
Nov-14	39.85	41.26	41.79	39.33
Nov-17	41.28	40.15	41.58	39.75
Nov-18	39.80	40.47	43.59	39.30
Nov-19	41.06	38.97	41.29	38.90
Nov-20	39.51	38.09	39.92	37.06
Nov-21	38.01	40.45	40.58	37.43
Nov-24	41.10	44.26	44.85	40.43
Nov-25	44.26	46.79	46.92	43.72
Nov-26	47.39	57.71	59.15	45.09
Nov-28	56.39	52.70	56.67	52.08
Dec-1	52.37	56.25	57.27	52.23
Dec-2	55.91	57.95	59.27	55.75
Dec-3	58.63	65.08	66.23	58.63

Arrowhead Pharmaceuticals, Inc. Earnings

Arrowhead Pharmaceuticals, Inc. Earnings Report: Per Share Arrowhead Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Arrowhead Pharmaceuticals, Inc. Forecast Revenue Growth

Arrowhead Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Arrowhead Pharmaceuticals, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $1.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.49 per share, and a decrease next year of $3.13 per share.

* Arrowhead Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.